Newsroom

Newsroom

Press Releases

Date Title and Summary Additional Formats
March 5, 2021
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn. , March 05, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, effective February 17, 2021 , the independent directors approved one equity award under CHF Solution’s New-Hire Equity Incentive Plan, as material inducement to an individual entering
March 4, 2021
ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery Patients
EDEN PRAIRIE, Minn. , March 04, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, will participate in the first ERAS Cardiac Society Virtual Conference , broadcasting Live from Methodist
March 2, 2021
CHF Solutions, Inc. Announces 49.5 Percent Increase in Revenue for Fourth Quarter 2020 and Provides Company Update
EDEN PRAIRIE, Minn. , March 02, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter ended December 31, 2020 . Recent Highlights Revenue for the fourth quarter of 2020 was $2 million , an increase of 49.5% compared to the prior year period
February 16, 2021
CHF Solutions, Inc. To Announce Fourth Quarter 2020 Financial Results on March 2, 2021
EDEN PRAIRIE, Minn. , Feb. 16, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter 2020 financial results will be released on Tuesday, March 2, 2021 . The company will host a conference call and webcast at 9:00 AM ET that morning, during which
February 3, 2021
CHF Solutions Submits Patent Application for New and Improved Diagnostic Parameters to Support Hemodynamic Stability
EDEN PRAIRIE, Minn. , Feb. 03, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application to increase monitoring capabilities with its Aquadex
January 28, 2021
CHF Solutions’ Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients
EDEN PRAIRIE, Minn. , Jan. 28, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from its physician-led webinar discussing real-world experience using
January 21, 2021
CHF Solutions Offers Educational Event on Effective Fluid Management Strategies in Heart Failure Patients
EDEN PRAIRIE, Minn. , Jan. 21, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, physician-led webinar to discuss “Real-World Experience
January 19, 2021
CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer
EDEN PRAIRIE, Minn. , Jan. 19, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the appointment of President and Chief Operating Officer Nestor Jaramillo , Jr.
January 12, 2021
CHF Solutions Protects New Peripheral Vascular Access Catheter with Patent Application
EDEN PRAIRIE, Minn. , Jan. 12, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for a peripheral vascular access catheter for use with its
Displaying 11 - 19 of 19

Upcoming Events

More events are coming soon.
jump